International Journal of Molecular Medical Science, 2024, Vol.14, No.2, 132-143 http://medscipublisher.com/index.php/ijmms 142 Kaneto C.M., Nascimento J.S., Moreira M.C.R., Ludovico N.D., Santana A.P., Silva R.A.A., Silva-Jardim I., Santos J.L., Sousa S.M.B., and Lima P.S.P., 2017, MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophy, Brazilian Journal of Medical and Biological Research, 50: e6211. https://doi.org/10.1590/1414-431x20176211 PMid:29069223 PMCid:PMC5649865 Khalique O.K., and Bello N.A., 2019, Are we getting closer to the HEART of hypertensive heart disease?, Hypertension, 74(2): 257-259. https://doi.org/10.1161/HYPERTENSIONAHA.119.13169 PMid:31256720 PMCid:PMC6938583 Kontaraki J.E., Marketou M.E., Zacharis E.A., Parthenakis F.I., and Vardas P.E., 2014, MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage, Journal of the American Society of Hypertension, 8(6): 368-375. https://doi.org/10.1016/j.jash.2014.03.324 PMid:24794206 Levy E., Spahis S., Bigras J.L., Delvin E., and Borys J.M., 2017, The epigenetic machinery in vascular dysfunction and hypertension, Current Hypertension Reports, 19(6): 52. https://doi.org/10.1007/s11906-017-0745-y PMid:28540644 Li T., Wang W., Gan W., Lv S., Zeng Z., Hou Y., Yan Z., Zhang R.X., and Yang M., 2022, Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy, Aging (Albany NY): 14(3): 1508. https://doi.org/10.18632/aging.203894 PMid:35157609 PMCid:PMC8876903 Liu C.F., and Tang W.W., 2019, Epigenetics in cardiac hypertrophy and heart failure, JACC: Basic to Translational Science, 4(8): 976-993. https://doi.org/10.1016/j.jacbts.2019.05.011 PMid:31909304 PMCid:PMC6938823 Liu L., He X., Zhao M., Yang S., Wang S., Yu X., Liu J.K., and Zang W., 2019, Regulation of DNA methylation and 2-OG/TET signaling by choline alleviated cardiac hypertrophy in spontaneously hypertensive rats, Journal of Molecular and Cellular Cardiology, 128: 26-37. https://doi.org/10.1016/j.yjmcc.2019.01.011 PMid:30660679 Meder B., Haas J., Sedaghat-Hamedani F., Kayvanpour E., Frese K., Lai A., Nietsch R., Scheiner C., Mester S., Bordalo D.M., Amr A., Dietrich C., Pils D., Siede D., Hund H., Bauer A., Holzer D.B., Ruhparwar A., Mueller-Hennessen M., Weichenhan D., Plass C., Weis T., Backs J., Wuerstle M., Keller A., Katus H.A., and Posch A.E., 2017, Epigenome-wide association study identifies cardiac gene patterning and a novel class of biomarkers for heart failure, Circulation, 136(16): 1528-1544. https://doi.org/10.1161/CIRCULATIONAHA.117.027355 PMid:28838933 Muka T., Koromani F., Portilla E., O'Connor A., Bramer W.M., Troup J., Chowdhury R., Dehghan A., and Franco O.H., 2016, The role of epigenetic modifications in cardiovascular disease: a systematic review, International Journal of Cardiology, 212: 174-183. https://doi.org/10.1016/j.ijcard.2016.03.062 PMid:27038728 Napoli C., Benincasa G., Donatelli F., and Ambrosio G., 2020, Precision medicine in distinct heart failure phenotypes: focus on clinical epigenetics, American Heart Journal, 224: 113-128. https://doi.org/10.1016/j.ahj.2020.03.007 PMid:32361531 Nwabuo C.C., and Vasan R.S., 2020, Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy, Current Hypertension Reports, 22: 1-18. https://doi.org/10.1007/s11906-020-1017-9 PMid:32016791 Ojji D., Libhaber E., Lamont K., Thienemann F., and Sliwa K., 2020, Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world, Cardiovascular Diagnosis and Therapy, 10(2): 296. https://doi.org/10.21037/cdt.2019.09.10 PMid:32420112 PMCid:PMC7225418 Rask-Andersen M., Martinsson D., Ahsan M., Enroth S., Ek W.E., Gyllensten U., and Johansson Å., 2016, Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction, Human Molecular Genetics, 25(21): 4739-4748. https://doi.org/10.1093/hmg/ddw302 PMid:28172975 Shenasa M., and Shenasa H., 2017, Hypertension, left ventricular hypertrophy, and sudden cardiac death, International Journal of Cardiology, 237: 60-63. https://doi.org/10.1016/j.ijcard.2017.03.002 PMid:28285801
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==